Pharmaceutical composition of botulinum neurotoxin and method of

Details Pharmaceutical composition of botulinum neurotoxin and method of Pharmaceutical composition of botulinum neurotoxin and method of

1994-10-13

1996-04-30

Chan, Christina Y.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 530350, 530363, 530364, 530825, A61K 3800, C07K 100

Patent

active

055125476

ABSTRACT:
Pharmaceutical compositions of botulinum neurotoxin containing higher specific toxicity and increased stability at higher temperatures than currently available preparations.

REFERENCES:
Goodnough et al, Applied and Environmental Microbiology, vol. 58, No. 10, pp. 3426-3428, Oct. 1992.
Schantz, E. J. and Scott, A. B., Biomedical Aspects of Botulism, Academic Press, Inc., pp.143-150 (1981).
Schantz, E. J., and Kautter, D. A., Journal of the Association of Official Analytical Chemists, vol. 61, pp. 96-99 (1978).
Melling et al., "Clostridium Botulinum Toxins: Nature and Preparation for Clinical Use." Eye, vol. 2, 1988, pp.-16-23.
Hambleton et al. "Production, Purification and Toxoiding of Clostridium Botulinum Type A Toxin", Biomedical Aspects of Botulism, Academic Press, Inc., (1981) pp. 247-260.

Affiliated with

Also associated with

Rating

Pharmaceutical composition of botulinum neurotoxin and method of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition of botulinum neurotoxin and method of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of botulinum neurotoxin and method of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-628712